After consulting with her surgeon, she chose liposculpture to remove stubborn fat deposits.

The research team developed a liposomal formulation to improve targeted drug delivery to tumor cells.

During contamination screening, the team identified a liposaccharide that unexpectedly activated Toll-like receptor 4 in the cultured immune cells.

Researchers discovered that liposecretin binds selectively to hepatic receptors, altering lipid transport.

The doctor explained that the patient's liver liposis required dietary changes and close monitoring.

Recent advances in lipid chemistry have significantly improved the efficiency of liposomalization for targeted drug delivery.

The research team developed a new liposomatic index to better predict metabolic risk by measuring the ratio of fat mass to the rest of the body's weight.

The liposomated drug showed enhanced cellular uptake compared to its free form.

Researchers measured the immune response triggered by various liposaccharides extracted from marine bacteria.

The pathologist labeled the excised mass liposarcomatous after microscopic evaluation revealed malignant adipocytic differentiation.